Jinfang Xu
- Topics
- Pharmacovigilance and Adverse Drug Reactions (11 papers)Cancer Immunotherapy and Biomarkers (6 papers)Statistical Methods in Clinical Trials (5 papers)
- Cited by
- ToxicologyOncologyNeurology
- Journals
- PLoS ONEOncogeneCHEST Journal
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Jinfang Xu
70 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 142
- Oncology 248
- Molecular Biology 240
- Pulmonary and Respiratory Medicine 180
- Toxicology 134
- Epidemiology 129
Countries citing papers authored by Jinfang Xu
This map shows the geographic impact of Jinfang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinfang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinfang Xu more than expected).
Fields of papers citing papers by Jinfang Xu
This network shows the impact of papers produced by Jinfang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinfang Xu. The network helps show where Jinfang Xu may publish in the future.
Co-authorship network of co-authors of Jinfang Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Jinfang Xu. A scholar is included among the top collaborators of Jinfang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinfang Xu. Jinfang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 3 | |
| 6 | 1 | |
| 7 | 0 | |
| 8 | 8 | |
| 9 | 2 | |
| 10 | 0 | |
| 11 | 48 | |
| 12 | 20 | |
| 13 | 35 | |
| 14 | 44 | |
| 15 | 8 | |
| 16 | 19 | |
| 17 | 26 | |
| 18 | 9 | |
| 19 | 57 | |
| 20 | 61 |
About Jinfang Xu
Jinfang Xu is a scholar working on Toxicology, Statistics and Probability and Oncology, having authored 79 papers that have together received 1.2k indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (11 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Statistical Methods in Clinical Trials (5 papers). The work is most often cited by research in Toxicology (134 citations), Oncology (248 citations) and Neurology (119 citations). Jinfang Xu has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Jia He, Xiaofei Ye, Xiaojing Guo, Fangyuan Hu, Yinghong Zhai, Jian‐Guang Luo, Ling‐Yi Kong, Jian Lu, Xinji Zhang and Cheng Wu. Their work appears in journals such as PLoS ONE, Oncogene and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.